Cargando…
Alteration of chromatin high‐order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells
Oxaliplatin is a first‐line chemotherapy drug widely adopted in colorectal cancer (CRC) treatment. However, a large proportion of patients tend to become resistant to oxaliplatin, causing chemotherapy to fail. At present, researches on oxaliplatin resistance mainly focus on the genetic and epigeneti...
Autores principales: | Li, Peilong, Shang, Xueying, Jiao, Qinlian, Mi, Qi, Zhu, Mengqian, Ren, Yidan, Li, Juan, Li, Li, Liu, Jin, Wang, Chuanxin, Shi, Yi, Wang, Yunshan, Du, Lutao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624369/ https://www.ncbi.nlm.nih.gov/pubmed/37933235 http://dx.doi.org/10.1002/EXP.20220136 |
Ejemplares similares
-
Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28
por: Zhang, Shujun, et al.
Publicado: (2023) -
Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2019) -
Correction to: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2020) -
Retraction Note: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2022) -
Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells
por: Du, Lutao, et al.
Publicado: (2020)